Health
EU regulator probes possible kidney damage from coronavirus drug – Macau Business
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir, made by US pharma giant Gilead.
The European Medicines Agency recommended the use of the anti-viral drug, sold under the brand name Veklury, in June after studies showed it could reduce the length of hospital stays for Covid-19 sufferers.
“EMA’s safety committee has started a review… to assess reports of acute kidney injury in some patients …
-
Noosa News21 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Noosa News19 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
Business20 hours agoInvested in IAG shares? Here are the key dates for FY26
-
Noosa News23 hours agoWhy the Story Bridge won’t have a traffic lane repurposed for bikes and walkers